8 HR Carbidopa 36.25 MG Levodopa 145 MG Extended Release Oral Capsule Rytary
1 INDICATIONS AND USAGE RYTARY is indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. RYTARY is a combination of carbidopa (an aromatic amino acid decarboxylation inhibitor) and levodopa (an aromatic amino acid) indicated for the treatment of Parkinson's disease, post-encephalitic parkinsonism, and parkinsonism that may follow carbon monoxide intoxication or manganese intoxication ( 1 )
amneal pharmaceuticals llc
CAPSULE BLUE IPX066 145
Related Pills
8 HR Carbidopa 61.25 MG Levodopa 245 MG Extended Release Oral Capsule Rytary
amneal pharmaceuticals llc
8 HR Carbidopa 48.75 MG Levodopa 195 MG Extended Release Oral Capsule Rytary
amneal pharmaceuticals llc
8 HR Carbidopa 23.75 MG Levodopa 95 MG Extended Release Oral Capsule Rytary
amneal pharmaceuticals llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 16.1 How Supplied RYTARY (
CARBIDOPA AND LEVODOPA) Extended-Release capsules are available in the following strengths: 23.75 mg Carbidopa and 95 mg of Levodopa: blue and white capsule imprinted with IPX066 on the capsule cap and 95 on the capsule body. They are available as follows: Bottles of 100: (NDC 64896-661-01) Bottles of 240: (NDC 64896-661-43) 36.25 mg Carbidopa and 145 mg Levodopa: blue and light blue capsule imprinted with IPX066 on the capsule cap and 145 on the capsule body. They are available as follows: Bottles of 100: (NDC 64896-662-01) Bottles of 240: (NDC 64896-662-43) 48.75 mg Carbidopa and 195 mg Levodopa: blue and yellow capsule imprinted with IPX066 on the capsule cap and 195 on the capsule body. They are available as follows: Bottles of 100: (NDC 64896-663-01) Bottles of 240: (NDC 64896-663-43) 61.25 mg Carbidopa and 245 mg Levodopa: blue capsule imprinted with IPX066 on the capsule cap and 245 on the capsule body. They are available as follows: Bottles 100: (NDC 64896-664-01) Bottles of 240: (NDC 64896-664-43) 16.2 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Store in a tightly closed container, protected from light and moisture. Dispense in a tightly closed, light-resistant container.
More pills like CAPSULE IPX066 145